Matteo Bianco Selected Research

Aspirin (Acetylsalicylic Acid)

4/2024	Current Strategies to Guide the Antiplatelet Therapy in Acute Coronary Syndromes.
12/2022	Left Ventricular Thrombus Management After Acute Myocardial Infarction in Clinical Practice: Results from LEVITATION Survey and Narrative Review.
12/2022	[ANMCO Position paper: Evidence and practical indications for the use of low-dose rivaroxaban in stable coronary artery disease and peripheral artery disease].
4/2022	Net clinical benefit of different strategies of dual antiplatelet therapy in elderly patients: Data from the praise registry.
1/2022	[Management of ST-elevation myocardial infarction in a patient with aspirin hypersensitivity without oral P2Y12 inhibitors].
1/2020	Is oral anticoagulation effective in preventing transcatheter aortic valve implantation failure? A propensity matched analysis of the Italian Transcatheter balloon-Expandable valve Registry study.
4/2019	Management of aspirin intolerance in patients undergoing percutaneous coronary intervention. The role of mono-antiplatelet therapy: a retrospective, multicenter, study.
1/2017	Aspirin Desensitization in Patients With Coronary Artery Disease: Results of the Multicenter ADAPTED Registry (Aspirin Desensitization in Patients With Coronary Artery Disease).
1/2016	Efficacy and Safety of Available Protocols for Aspirin Hypersensitivity for Patients Undergoing Percutaneous Coronary Intervention: A Survey and Systematic Review.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matteo Bianco Research Topics

Disease

13	Hemorrhage 04/2024 - 06/2016
8	Acute Coronary Syndrome 04/2024 - 03/2019
8	Myocardial Infarction 08/2023 - 06/2016
7	Thrombosis (Thrombus) 08/2023 - 06/2016
4	Coronary Artery Disease (Coronary Atherosclerosis) 01/2023 - 01/2017
3	Spontaneous Coronary Artery Dissection 03/2023 - 01/2021
3	Hypersensitivity (Allergy) 01/2022 - 01/2016
3	ST Elevation Myocardial Infarction 01/2022 - 01/2017
3	Stroke (Strokes) 01/2021 - 01/2020
2	Takotsubo Cardiomyopathy 05/2024 - 04/2018
2	Heart Failure 11/2023 - 01/2023
2	Cardiovascular Diseases (Cardiovascular Disease) 04/2022 - 03/2019
2	COVID-19 01/2022 - 01/2021
2	Amyloidosis 06/2021 - 01/2021
2	Anaphylaxis (Anaphylactic Shock) 04/2018 - 01/2017
1	Chronic Obstructive Pulmonary Disease (COPD) 12/2023
1	Embolic Stroke 11/2023
1	Atrial Fibrillation 11/2023
1	Cardiogenic Shock 08/2023
1	Ischemic Stroke 08/2023
1	Disease Progression 03/2023
1	Peripheral Arterial Disease 12/2022
1	Mental Disorders (Mental Disorder) 09/2022
1	Heart Arrest (Cardiac Arrest) 07/2022
1	Vomiting 01/2022
1	Pulmonary Embolism 01/2021
1	Cardiomyopathies (Cardiomyopathy) 01/2021
1	Transthyretin-Related Hereditary Amyloidosis 01/2021
1	Sepsis (Septicemia) 01/2021
1	Hemoptysis 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Infections 01/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Obesity 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Renal Insufficiency (Renal Failure) 01/2021
1	Unstable Angina 10/2020
1	Transient Ischemic Attack 01/2020
1	Ventricular Fibrillation 04/2018
1	Urticaria (Hives) 01/2017
1	Asthma (Bronchial Asthma) 01/2017
1	Angioedema 01/2017

Drug/Important Bio-Agent (IBA)

9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 04/2024 - 01/2016
4	omega-Chloroacetophenone (Mace)IBA 08/2023 - 03/2019
4	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 04/2022 - 06/2016
3	Clopidogrel (Plavix)FDA Link 12/2022 - 01/2016
3	TicagrelorIBA 04/2022 - 01/2020
2	Prasugrel Hydrochloride FDA Link 04/2022 - 01/2020
2	indobufenIBA 01/2022 - 01/2016
2	C-Reactive ProteinIBA 01/2021 - 01/2021
1	Biomarkers (Surrogate Marker)IBA 05/2024
1	DiureticsIBA 12/2023
1	Gonadal Steroid Hormones (Sex Hormones)IBA 03/2023
1	Hormones (Hormone)IBA 03/2023
1	RivaroxabanIBA 12/2022
1	cangrelorIBA 01/2022
1	Glycoproteins (Glycoprotein)IBA 01/2022
1	APTIBA 01/2022
1	Diphosphonates (Bisphosphonates)IBA 06/2021
1	Prealbumin (Transthyretin)IBA 06/2021
1	AcidsIBA 01/2021
1	N(4)-oleylcytosine arabinosideIBA 01/2021
1	ProcalcitoninIBA 01/2021
1	Transaminases (Aminotransferases)IBA 01/2021
1	CreatinineIBA 01/2021
1	Ferritins (Ferritin)IBA 01/2021
1	TroponinIBA 01/2021
1	Troponin IIBA 01/2021
1	Purinergic P2Y Receptor AntagonistsIBA 03/2019
1	Epinephrine (Adrenaline)FDA LinkGeneric 04/2018
1	Everolimus FDA Link 06/2016
1	zotarolimusIBA 06/2016

Therapy/Procedure

13	Therapeutics 04/2024 - 01/2016
8	Percutaneous Coronary Intervention 11/2023 - 01/2016
6	Stents 08/2023 - 06/2016
1	Contraindications 11/2023
1	Patient Readmission 08/2023
1	Bridge Therapy 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2022
1	Conservative Treatment 01/2021
1	Transcatheter Aortic Valve Replacement 01/2020